Transcend Therapeutics, founded in 2021, is a clinical-stage, neuroscience-focused company. It is dedicated to developing rapid-acting treatments for neuropsychiatric diseases.
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Transcend Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Transcend Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.